Aquigen Bio Strengthens Its Impurity Standards Portfolio with New High-Purity Compounds

HIGHLAND, Ind. - July 11, 2025 - PRLog -- In an era where pharmaceutical precision, regulatory compliance, and data integrity are non-negotiable, Aquigen Bio continues to set industry benchmarks in impurity standard development. With a relentless commitment to quality and innovation, the company has recently expanded its Impurity Standards catalog to include well-characterized, high-purity compounds for Halcinonide, Ibandronate, Kaempferol, and Labetalol.

Newly Released Impurity Standards by Aquigen Bio

1. Halcinonide Impurity 14
Halcinonide is a potent topical corticosteroid used for various dermatological conditions. Aquigen Bio now offers Halcinonide Impurity 14, designed to meet stringent pharmacopeial requirements and support stability studies and batch validation.

Ibandronate Impurity 3 & Impurity 4

High Purity Guarantee: All impurity standards are ≥95% pure (unless otherwise specified), with full documentation.
Comprehensive CoA: Each product is accompanied by validated HPLC, MS, and NMR data for reproducibility and reliability.
Global Reach: With a robust shipping and support network, Aquigen Bio serves clients in North America, Europe, Asia-Pacific, and the Middle East.
Research-Driven: Continuous product development focused on rare impurities and novel intermediates.

Product Page: https://aquigenbio.com/product/halcinonide-impurity-14/
Supporting Every Stage of Your Analytical Lifecycle
From method development to stability studies, validation, and batch release, Aquigen Bio's impurity standards play a pivotal role in helping pharmaceutical organizations maintain quality and meet evolving regulatory standards.

Impurity 3: https://aquigenbio.com/product/ibandronate-impurity-3/
Impurity 4: https://aquigenbio.com/product/ibandronate-impurity-4/